Nicolet Advisory Services LLC raised its stake in MetLife, Inc. (NYSE:MET – Free Report) by 6.0% in the 3rd quarter, Holdings Channel.com reports. The fund owned 6,927 shares of the financial services provider’s stock after buying an additional 393 shares during the quarter. Nicolet Advisory Services LLC’s holdings in MetLife were worth $563,000 at the end of the most recent reporting period.
A number of other institutional investors have also recently modified their holdings of the stock. MeadowBrook Investment Advisors LLC grew its stake in MetLife by 244.4% during the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after buying an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. increased its stake in shares of MetLife by 131.9% in the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 186 shares during the last quarter. Wolff Wiese Magana LLC raised its holdings in shares of MetLife by 374.3% during the 3rd quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after buying an additional 277 shares in the last quarter. Peterson Financial Group Inc. acquired a new stake in MetLife in the third quarter valued at about $30,000. Finally, Fortitude Family Office LLC grew its position in MetLife by 177.3% in the third quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock valued at $34,000 after acquiring an additional 266 shares during the last quarter. 89.81% of the stock is currently owned by institutional investors.
MetLife Stock Up 1.6 %
Shares of NYSE MET opened at $86.59 on Friday. The company’s 50 day moving average price is $82.48 and its 200-day moving average price is $76.05. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.16 and a current ratio of 0.16. MetLife, Inc. has a 52-week low of $62.81 and a 52-week high of $86.94. The company has a market capitalization of $59.96 billion, a P/E ratio of 17.46, a price-to-earnings-growth ratio of 0.77 and a beta of 1.05.
MetLife Dividend Announcement
Analyst Ratings Changes
A number of equities research analysts have recently weighed in on the stock. Morgan Stanley reduced their price target on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating on the stock in a research note on Monday, August 19th. Bank of America decreased their target price on shares of MetLife from $99.00 to $96.00 and set a “buy” rating on the stock in a research note on Thursday, August 1st. Piper Sandler increased their price target on MetLife from $85.00 to $92.00 and gave the company an “overweight” rating in a research note on Wednesday, October 2nd. Jefferies Financial Group upped their target price on MetLife from $89.00 to $95.00 and gave the stock a “buy” rating in a report on Friday, September 27th. Finally, Barclays cut their price target on MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a research note on Thursday, October 31st. Fourteen analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $88.46.
Get Our Latest Stock Analysis on MetLife
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- 10 Best Airline Stocks to Buy
- Vertiv’s Cool Tech Makes Its Stock Red-Hot
- How to Read Stock Charts for Beginners
- MarketBeat Week in Review – 11/18 – 11/22
- Are Penny Stocks a Good Fit for Your Portfolio?
- 2 Finance Stocks With Competitive Advantages You Can’t Ignore
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.